Á lódáil...
Risk of severe upper gastrointestinal complications among oral bisphosphonate users.
BACKGROUND: Oral bisphosphonates (BPs) are the primary agents for the treatment of osteoporosis. Although BPs are generally well tolerated, serious gastrointestinal adverse events have been observed. AIM: To assess the risk of severe upper gastrointestinal complications (UGIC) among BP users by mean...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
Public Library of Science (PLoS)
2013-01-01
|
Sraith: | PLoS ONE |
Rochtain Ar Líne: | http://europepmc.org/articles/PMC3857168?pdf=render |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|